Skip to main content

Advertisement

Table 1 Demographic data of controls and type 2 diabetes

From: Substantial fibrin amyloidogenesis in type 2 diabetes assessed using amyloid-selective fluorescent stains

Healthy individuals (N = 34)
  Gender   Age   BMI: normal: < 24.9; overweight: > 25
%; median; STD Age-controlled healthy individuals (n = 17)
 F: 82%; M: 18%   61 (± 11)   < 24.9: 47%; > 25: 53%
Young healthy individuals (n = 17)
 F: 24% M: 76%   22 (± 4)   < 24.9: 88%; > 25: 12%
  1. Statistical analysis was performed with the Mann–Whitney U test, using the STATSDIRECT (version 2.8.0) software
Type 2 diabetes individuals (N = 33; BMI: > 25)
  Gender Age HbA1c (%) Chol (mMol L−1) % with dyslipidaemia (%) % with hypertension (%) % with using anti-coagulants (%)
%; median; STD F: 39% M: 61% 62 (± 11) 7 (± 1.2) 3.95 (± 0.74) 79 61 55
  1. Statistical analysis was performed with the Mann–Whitney U test, using the STATSDIRECT (version 2.8.0) software